Entering text into the input field will update the search result below

Core One acquires GMP Drug to bolster psychedelics production

Jan. 16, 2023 4:31 AM ETCore One Labs Inc. (CLABF) StockBy: Ravikash Bakolia, SA News Editor1 Comment

word M and A made with wood building blocks, concept

Maks_Lab

Core One Labs (OTCQB:CLABF) acquired GMP Drug in a deal worth C$2.8M common stock plus bonus shares to pave the way to become a full-cycle psychedelics supply chain solution provider.

Privately held GMP Drug operates through a Good Manufacturing

Recommended For You

About CLABF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLABF--
Core One Labs Inc.